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E-cadherin expression in 
macrophages dampens their 
inflammatory responsiveness  
in vitro, but does not modulate 
M2-regulated pathologies in vivo
Jan Van den Bossche1,2,†, Damya Laoui1,2, Thomas Naessens3, Hermelijn H. Smits4, 
Cornelis H. Hokke4, Benoît Stijlemans1,2, Johan Grooten3, Patrick De Baetselier1,2 & 
Jo A. Van Ginderachter1,2
IL-4/IL-13-induced alternatively activated macrophages (M(IL-4/IL-13), AAMs or M2) are known to 
express E-cadherin, enabling them to engage in heterotypic cellular interactions and IL-4-driven 
macrophage fusion in vitro. Here we show that E-cadherin overexpression in Raw 264.7 macrophages 
inhibits their inflammatory response to LPS stimulation, as demonstrated by a reduced secretion of 
inflammatory mediators like interleukin (IL)-6, tumor necrosis factor (TNF) and nitric oxide (NO). To 
study the function of E-cadherin in M(IL-4/IL-13) macrophages in vivo, we generated macrophage-specific 
E-cadherin-deficient C57BL/6 mice. Using this new tool, we analyzed immunological parameters 
during two typical AAM-associated Th2-driven diseases and assessed Th2-associated granuloma 
formation. Although E-cadherin is strongly induced in AAMs during Taenia crassiceps helminth 
infections and allergic airway inflammation, its deletion in macrophages does not affect the course of 
both Th2 cytokine-driven diseases. Moreover, macrophage E-cadherin expression is largely redundant 
for granuloma formation around Schistosoma mansoni ova. Overall, we conclude that E-cadherin 
is a valuable AAM marker which suppresses the inflammatory response when overexpressed. Yet 
E-cadherin deletion in macrophages does not affect M(LPS+IFNγ) and M(IL-4) polarization in vitro, nor in 
vivo macrophage function, at least in the conditions tested.
Depending on the microenvironment, macrophages are polarized to different subsets which have been 
broadly classified as M1 and M2. Classically activated macrophages (CAMs or M1) are induced by Th1 
inflammatory cytokines, such as IFN-γ , and by microbial or endogenous danger-associated molecules. 
According to the latest nomenclature guidelines, CAMs or M1 are now classified as M(LPS), M(IFNγ) or 
M(LPS+IFNγ), depending on the activators used to generate them1. These inflammatory macrophages 
produce cytokines like IL-1β , IL-6, IL-12 and TNF and express high levels of inducible nitric oxide 
synthase (iNOS)2, which makes them potent effector cells to combat microorganisms and potentially 
also tumor cells. Macrophages are also activated by anti-inflammatory mediators, including the Th2 
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cytokines interleukin-4 (IL-4) and IL-13, IL-10, transforming growth factor-β (TGF-β ), glucocorticoids, 
and immune complexes. While all these types of ‘non-M1’ macrophages are often grouped under the 
generic term M23, this nomenclature is often indistinct and confusing1,4. Therefore, the formerly so-called 
IL-4 (and/or IL-13)-induced alternatively activated macrophages (AAMs) are now termed M(IL-4) or 
M(IL-4/IL-13)1. M(IL-4/IL-13) inhibit Th1/M1-driven inflammatory responses, promote Th2 responses, induce 
angiogenesis and wound repair, and can be immunosuppressive5. However, it is not fully-understood 
how these diverse functions are regulated at the molecular level.
We previously identified E-cadherin as a novel IL-4/IL-13-induced, STAT6/polyamine-dependent 
marker for M(IL-4/IL-13)6,7. E-cadherin co-localizes with β - and p120-catenin at the cell surface, enabling 
M(IL-4/IL-13) macrophages to undergo homotypic adhesive interactions, leading to cell fusion upon IL-4 
treatment in vitro. Macrophages still fuse in the absence of E-cadherin, but the number of nuclei in each 
giant cell and their size is reduced6. In fact, different IL-4-induced molecules, including E-cadherin, 
DC-STAMP and TREM-2, need to cooperate to induce fusion-competent macrophages8,9. Furthermore, 
E-cadherin+ macrophages engage in heterotypic interactions with KLRG1+ and CD103+ cells in vitro. 
Upon ligation, KLRG1 inhibits TCR signaling and NK cytotoxicity which could be a way for E-cadherin+ 
cells to impair inflammatory immune responses10. Interestingly, CD103 is found on major mediators of 
the immune response, such as DC and T cell subsets11,12. Hence, E-cadherin might serve to bring these 
cells in closer contact with macrophages, thereby potentially influencing their retention and phenotype 
during polarized Th2 responses.
Besides their function in cell adhesion, E-cadherin and its associated catenins may modulate intracel-
lular signaling molecules, including β -catenin/Wnt13, phosphatidylinositol 3-kinase (PI3K)14, Rho-family 
GTPases15 and NFκ B16–18. As such, E-cadherin reduces the inflammatory response in keratinocytes 
and epithelial cells. Furthermore, KLRG1 engagement of E-cadherin on DCs lowers their secretion of 
inflammatory cytokines, thereby exerting immunosuppressive effects19. Hence, it is conceivable that the 
E-cadherin/catenin complex might exert similar activities in macrophages and could contribute to the 
anti-inflammatory character and immunoregulatory capacity of alternatively activated M(IL-4/IL-13) during 
Th2 responses.
We demonstrate here that E-cadherin overexpression indeed suppresses the secretion of inflammatory 
mediators. Yet, while E-cadherin is a valuable marker for polarized Th2 responses and M(IL-4/IL-13), its 
macrophage-specific deletion has no major in vivo effects on macrophage activity during Th2 responses, 
nor on cell fusion during Schistosoma mansoni granuloma formation.
Results
E-cadherin expression in Raw264.7 macrophages reduces their inflammatory phenotype 
upon stimulation. Besides its well-described role as an adhesive molecule, E-cadherin influences 
inflammatory signaling pathways such as NF-κ B and thereby inhibits the inflammatory activation of 
various cell types16–18. As such, E-cadherin is now emerging as a potentially important immunologi-
cal regulator20,21. To test the effect of E-cadherin expression on inflammatory cues in macrophages, we 
generated four independent E-cadherin over-expressing Raw264.7 transfectants and four E-cadherin-
negative mock transfectants (Figure S1A). LPS dose-dependently induced TNF and IL-6 secretion by 
Raw264.7 macrophages after 24 h stimulation and this response was significantly lowered in E-cadherin-
overexpressing transfectants (Fig. 1A). Even at the highest LPS concentration, E-cadherin was still able 
to inhibit LPS-induced production of inflammatory cytokines. Moreover, NO induction by IFNγ and 
increasing concentrations of LPS was reduced in macrophages that express E-cadherin. Conversely, 
E-cadherin overexpression did not affect M(IL-4) polarization as illustrated by the unaltered IL-4-induced 
surface expression of Macrophage Mannose Receptor (MMR, CD206), Macrophage Galactose-type 
C-type Lectin (MGL, CD301), and Transferrin Receptor 1 (CD71) (Fig. 1B). Together, these data show 
that E-cadherin actively participates in down-tuning the macrophage inflammatory responsiveness when 
overexpressed, a feature that would be consistent with its predominant expression in anti-inflammatory 
M(IL-4) macrophages.
In naive conditions, primary macrophages express very low levels of E-cadherin6. To assess whether 
E-cadherin deletion at baseline would affect subsequent M(LPS+IFNγ) polarization in primary macrophages, 
E-cadherin-deficient bone marrow-derived macrophages (LysM-cre x Cdh1F/F, termed Cdh1Δ) were 
generated and treated with LPS+ IFNγ . These cells displayed a similar M(LPS+IFNγ) polarization as their 
WT (Cdh1F/F) counterparts (Fig.  1C) in vitro. Accordingly, we did not observe differences in survival 
between Cdh1Δ and Cdh1F/F mice upon LPS-induced sepsis as typical M1 response in vivo (Figure 
S1B). Moreover, bone marrow-derived macrophages from Cdh1Δ and Cdh1F/F mice displayed similar 
M(IL-4) polarization (Fig.  1D), phagocytosis and autophagy (Figure S1C,D). Hence, only high levels of 
E-cadherin at baseline alter the responsiveness to a subsequent inflammatory insult.
Cdh1Δ and control mice are equally susceptible to Taenia crassiceps infection. Next, we set 
out to investigate the immunoregulatory role of E-cadherin in M(IL-4/IL-13) macrophages in vivo by assess-
ing the course of Th2- and M(IL-4/IL-13)-associated diseases in Cdh1Δ versus Cdh1F/F mice. Taenia crassiceps 
helminths initially induce a Th1 response which becomes highly Th2 polarized after 4 weeks of infection, 
resulting in the accumulation of M(IL-4/IL-13) macrophages that are essential for the in vivo maintenance of 
the parasite22. Hence, an alteration of the macrophage activation state, possibly triggered by the absence 
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Figure 1. E-cadherin-overexpressing Raw264.7 macrophages display reduced inflammatory 
responses. Raw-E-cadherin and Raw-Mock transfectants (n = 4) were left untreated or were stimulated 
for 24 h with (A) indicated concentrations LPS (+ IFNγ ) or (B) IL-4. Similarly, BMDM from naive 
Cdh1Δ and Cdh1F/F mice (n = 3) were treated with (C) 10 ng/ml LPS + 10 U/ml IFNγ or (D) with IL-4. 
MLPS(+IFNγ) and MIL-4 polarization was assessed by measuring the secretion of IL-6, IL-12, TNF and NO 
or by determining the IL-4-induced surface expression MRC1, MGL, TFRC1 and PDL2, respectively. 
IL-12 secretion was not detected in Raw264.7 cells and these cells did not show IL-4-induced PDL2 
upregulation. Data represent the mean ± SEM of 4 individual Raw264.7 clones (A,B) or BMDM from 
3 individual mice (C,D). Δ MFI = [median fluorescence intensity]positive staining − [median fluorescence 
intensity]isotype control. *P < .05; **P < .01; ***P < .001
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of E-cadherin, might impact the course of this infectious disease. In the peritoneal exudate cells from 
14 weeks infected WT mice, surface expression of E-cadherin was confined to CD11bhiLy6ChiMHC-IIhi 
immature macrophages and CD11bhiLy6CloMHC-IIhi mature macrophages. This expression is blunted in 
Cdh1Δ mice, illustrating the efficiency of the gene deletion in macrophages (Fig. 2A). However, parasite 
load as well as the total cell counts were similar in the peritoneal cavities of Cdh1Δ and Cdh1F/F infected 
mice at all time points measured (Fig.  2B). In addition, the peritoneal cellular composition, gated as 
shown in Figure S2, is largely comparable between both mouse strains (Fig.  2C), excluding a major 
impact of E-cadherin expression in macrophages on the course of this disease. We next focussed specifi-
cally on the activation state of peritoneal macrophages from late-stage infected Cdh1F/F and Cdh1Δ mice. 
Macrophages from both strains had a similar arginase activity and spontaneously secreted comparable 
levels of NO, TNF, IL-6 and IL-10 upon in vitro culture (Fig. 3A), suggesting no major differences in the 
inflammatory status of these in vivo-elicited populations. Finally, we assessed the LPS responsiveness of 
the E-cadherin+ Cdh1F/F macrophages versus the E-cadherin− Cdh1Δ macrophages from infected mice. 
As illustrated in Fig. 3B,C, these in vivo-elicited cells produced similar amounts of NO, TNF, IL-6 and 
Figure 2. Cdh1Δ mice are equally susceptible to Taenia crassiceps infection. (A) Freshly isolated 
peritoneal cells from T. crassiceps infected Cdh1F/F and Cdh1Δ mice (14 weeks p.i.) were subjected to 
multicolour FACS analysis. Myeloid and non-myeloid (G1) cells were first gated based on CD11b expression. 
Within the CD11b+ myeloid cell gate, Ly6C-MHC II staining discriminates between Ly6Cint/MHC IIneg 
eosinophils and neutrophils, Ly6Chigh/MHC IIneg inflammatory monocytes, Ly6Chi/MHC IIpos immature 
macrophages and Ly6Clow/MHC IIhigh mature macrophages. The histograms show an overlay of isotype 
staining (grey, filled) and anti-E-cadherin staining (bold line) on these gated peritoneal cell types from T. 
crassiceps infected Cdh1F/F (top) and Cdh1Δ (bottom) mice. (B) Parasite load (top) and total leukocyte cell 
count (bottom) is similar in the peritoneal cavities of Cdh1Δ and Cdh1F/F infected mice at all indicated time 
points. (C) Peritoneal cells from T. crassiceps infected Cdh1F/F and Cdh1Δ mice were isolated at indicated 
time point and subjected to multicolour FACS analysis and all leukocyte populations were gated as shown 
in Figure S2. The absolute number of macrophages, eosinophils, inflammatory monocytes, immature 
macrophages, neutrophils, B cells and CD4+ and CD8+ T cells in the peritoneal cavities of T. crassiceps 
infected Cdh1F/F and Cdh1Δ mice (average ± SEM of 5 mice per group per time point) is shown.
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IL-10, both spontaneously and upon LPS or LPS+ IFN-γ stimulation in vitro. In conclusion, during a 
helminth infection that strongly polarizes the macrophages towards M(IL-4/IL-13), the lack of E-cadherin 
in these cells is not sufficient to alter their activation state and to have an impact on the outcome of the 
disease.
Cdh1Δ and control mice are equally susceptible to allergic airway inflammation, but Cdh1Δ 
mice display lower B cell counts in their BAL. To further assess a potential role for macrophage 
E-cadherin during strongly polarized Th2-associated pathologies, we turned to a model of ovalbu-
mine (OVA)-induced allergic airway inflammation. Sensitized mice were either challenged twice (short 
term protocol 2× OVA) or four times (long term protocol 4× OVA) with OVA allergen, during which 
E-cadherin-expressing alveolar macrophages (CD11chigh F4/80+ MHC-II+ autofluorescence (AF)high cells) 
and DCs (CD11chigh F4/80− MHC-IIhi AFlow cells) are induced (Fig. 4A for 4× OVA, data not shown for 
2× OVA). Again, the E-cadherin expression was absent in Cdh1Δ mice. While two ovalbumin challenges 
(2× OVA) were sufficient to induce an initial modest inflammatory response with faintly increased IL-4 
and IL-5 levels in the bronchoalveolar lavage (BAL), the inflammation and associated secretion of IL-4, 
IL-5 and IL-17 were further increased by two additional ovalbumin challenges (4× OVA). However, no 
significant differences in BAL cytokine concentrations were observed between Cdh1Δ and Cdh1F/F con-
trol mice (Fig. 4B). In agreement with the similar cytokine profiles, Cdh1Δ and Cdh1F/F mice had compa-
rable total BAL cell numbers (gated as shown in Figure S3) and a comparable recruitment of eosinophils, 
neutrophils and T cells to the alveolar space. Surprisingly, B cell counts were consistently lower in the 
Figure 3. Peritoneal macrophages from Cdh1F/F and Cdh1Δ T. crassiceps-infected mice display a similar 
activation status. (A) Peritoneal macrophages obtained from Cdh1F/F and Cdh1Δ mice at different time 
points after infection display similar arginase activity and spontaneously secrete equal levels of NO, TNF, 
IL-6 and IL-10 upon 24 h in vitro culture. Additionally, these in vivo-elicited cells secrete similar amounts 
of NO, TNF, IL-6 and IL-10 upon (B) LPS and (C) LPS+ IFN-γ stimulation. Values are the mean ± SEM of 
5 mice per group per time point.
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BAL of Cdh1Δ mice (Fig.  4C). Overall, deletion of macrophage (and DC) E-cadherin expression does 
not seem to affect the severity of ovalbumine-induced allergic airway responses.
Cdh1Δ mice display normal granuloma formation during schistosomiasis. Earlier findings 
from our lab and others showed an involvement of E-cadherin in IL-4-mediated macrophage fusion 
leading to multinucleated giant cell formation in vitro6,23, but the in vivo relevance of these findings 
remained unaddressed. As a model system, we intravenously challenged Cdh1Δ and Cdh1F/F mice with 
Schistosoma mansoni eggs24, resulting in the induction of a polarized Th2 immune response and the 
formation of large pulmonary granulomas consisting mainly of eosinophils and macrophages (Fig. 5A). 
IL-4/IL-13-dependent formation of multinucleated giant cells is a hallmark of such granulomatous 
responses, suggesting a potential role for macrophage E-cadherin in this process25. However, no sig-
nificant differences were found in granuloma size (Fig.  5B) nor cross-sectional area (Fig.  5C) between 
Cdh1Δ and Cdh1F/F mice at 7 and 14 days post challenge. In both mouse strains the granuloma size and 
area equally decreased from day 7 to day 14 post challenge. Moreover, the cell density within the gran-
uloma (Fig. 5D) and its composition (as measured by the percentage eosinophils, Fig. 5E) was the same 
Figure 4. Cdh1Δ mice are equally susceptible to ovalbumine-induced allergic airway inflammation. 
Allergic asthma was induced in Cdh1F/F and Cdh1Δ animals by ovalbumin sensitization with Alum adjuvant, 
followed by 2 (2× OVA, short term protocol) or 4 (4× OVA, long term protocol) ovalbumin aerosols. (A) 
Cells in the bronchoalveolar lavage (BAL) were stained with anti-CD11c, anti-F4/80, anti-MHC II and anti-
E-cadherin or isotype control and analysed via FACS. Within gated CD11chigh BAL, a distinction was made 
between autofluorescence (AF)low MHC IIhigh DC and AFhigh F4/80+ alveolar macrophages and histogram 
overlays of isotype staining (grey, filled) and anti-E-cadherin staining (bold line) are shown for 4× OVA-
challenged Cdh1F/F (top) and Cdh1Δ (bottom) mice. (B) IFN-γ , IL-4, IL-5 and IL-17 concentrations were 
measured in the BAL fluid of Cdh1F/F (black bars) and Cdh1Δ (white bars) mice. (C) Different leukocyte 
populations in the BAL of 2× and 4× ovalbumin-challenged Cdh1F/F and Cdh1Δ mice were gated as in 
Figure S3 and absolute cell counts are shown (average ± SEM of 5 mice per group per time point). *P < .05.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:12599 | DOi: 10.1038/srep12599
in both mouse strains. Overall, we have no evidence to conclude that macrophage E-cadherin expression 
contributes to granuloma formation in the lungs after intravenous S. mansoni egg challenge.
Discussion
Parasitic helminths and allergens induce polarized Th2 responses, supporting alternative macrophage 
activation. While M(IL-4/IL-13) macrophages are key regulators of these diseases26,27, discriminative surface 
markers allowing their identification and contributing to their function remained limited. Previously, 
we identified E-cadherin as a protein that associates with IL-4/IL-13-exposed mouse and human mac-
rophages that can be employed as useful reporter of polarized Th2 responses and M(IL-4/IL-13) macrophages6.
While E-cadherin clearly contributes to IL-4-driven macrophage fusion and the formation of mult-
inucleated giant cells in vitro6,23, the in vivo significance of this observation remained unstudied so far. 
In this context, we here assessed E-cadherin’s contribution to granuloma formation during schistosomi-
asis in vivo. Schistosoma mansoni eggs are potent inducers of M(IL-4/IL-13) macrophages, and granuloma 
formation around these ova is an important characteristic of schistosomiasis28,29. ‘Granuloma closure’, 
preventing the diffusion of parasitic substances to the surroundings, is an important event and cad-
herins are documented to be expressed during this process30. As such, macrophage E-cadherin could 
serve to bring granulomatous cells into close contact, allowing the formation a compactly packed cell 
mass around the schistosome egg. Nevertheless, an experimental intravenous challenge with Schistosoma 
mansoni eggs equally induced granuloma formation in the lungs of Cdh1Δ and Cdh1F/F mice. In addi-
tion, no differences in granuloma parameters could be observed between these mouse strains. Probably 
a wide range of fusiogenic molecules is involved during the compaction of granulomas, and deleting 
one (in this case E-cadherin) in one of the participating granulomatous cell types (here macrophages) 
Figure 5. Cdh1Δ mice display normal granuloma formation during schistosomiasis. (A) H&E stained 
lung sections from Schistosoma mansoni egg-challenged Cdh1F/F and Cdh1Δ mice containing a representative 
granuloma are shown at 10× (top) and 20× (bottom) magnification. (B) The granuloma size (calculated as 
V = 4/3*Π *r3), (C) the granuloma cross-sectional area, (D) the granuloma density (calculated as the amount 
of cells per 104 μ m2) and (E) the percentage eosinophils within each granuloma is shown after 7 and 14 days 
post egg challenge (average ± SEM, n = 5 mice per group per time point).
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is not enough to impair this process. Overall, we have no data to conclude that macrophage E-cadherin 
expression is fundamental for granuloma formation. Together our findings support a model whereby a 
complex collection of molecules interact to form multinucleated giant cells and granulomas, as suggested 
earlier31,32. Within this collection of participating molecules, redundancy might exist, as is demonstrated 
here for E-cadherin.
Besides its potential contribution to macrophage fusion, E-cadherin enables M(IL-4/IL-13) macrophages 
to interact with KLRG1+ cells and to trap α Eβ 7 integrin (CD103)-expressing cells in vitro6. Both KLRG1 
and CD103 are E-cadherin ligands and are detected on major mediators of the immune system, includ-
ing DC, NK and T cell subpopulations11,12,21,33,34. As such, E-cadherin on M(IL-4/IL-13) macrophages might 
influence the retention of these cells in order to instruct their phenotype during Th2 immune responses. 
In parallel to its role during cell/cell interactions, the E-cadherin/catenin complex regulates inflammatory 
cascades in epithelial cells16,18 and thus might also modulate the phenotype of macrophages. In this con-
text, possible effects of enhanced macrophage E-cadherin expression on NFκ B, PI3K and β -catenin/Wnt 
signaling might modulate the macrophage activation status in a subtle manner. Indeed, these pathways 
are crucial to instruct the inflammatory phenotype of macrophages and are known to be modulated by 
E-cadherin and its different catenins in epithelial cells, keratinocytes, but also in tolerogenic DC13–17,21. 
Supporting this hypothesis, we showed here that E-cadherin over-expression in Raw 264.7 macrophage 
cell lines blunted the secretion of inflammatory mediators upon TLR engagement in vitro.
Doing so in vivo, macrophage E-cadherin could help to determine the outcome of typical Th2 
cytokine-driven diseases like Taenia crassiceps helminth infection and allergic asthma, during which 
E-cadherin-expressing M(IL-4/IL-13) macrophages are present. During the experimental mouse model of 
cysticercosis, infection with Taenia crassiceps evokes a Th1 response in the early phase of infection, 
which gradually switches to a Th2 response35,36. While Th2 responses are widely accepted to mediate 
protection against most helminths, a polarized STAT4-dependent, IL-12-mediated Th1 response and 
MIF-expressing inflammatory M1 macrophages are required to control Taenia crassiceps infections37–39. 
In accordance, STAT6-deficient mice, which lack AAMs and fail to induce Th2 responses, control Taenia 
crassiceps infections22,40. Based on the observations that E-cadherin has mainly inhibitory effects on 
pro-inflammatory signaling cascades in macrophages and other cell types, one would expect that Cdh1Δ 
mice have more M1-polarized macrophages and thus clear Taenia crassiceps helminths more efficiently. 
However, the course of parasitemia as well as the leukocyte count and cellular composition was similar 
in the peritoneum of Cdh1Δ and Cdh1F/F infected mice, ruling out an important role of E-cadherin 
expression in macrophages during cysticercosis (Fig. 2). Additionally, the lack of macrophage E-cadherin 
expression during this strongly Th2 polarizing disease did not affect the basal macrophage activation 
state, nor the LPS(+ IFNγ )-induced secretion of inflammatory factors (Fig.  3). In the latter case, an 
LPS+ IFNγ -mediated downregulation of E-cadherin6 could explain why no differences were observed 
between in vivo-elicited Cdh1Δ and Cdh1F/F macrophages.
Allergic asthma is another prototypical Th2 cytokine-driven disease which strongly instructs 
E-cadherin expression in M(IL-4/IL-13) macrophages. Yet, E-cadherin deletion in alveolar macrophages of 
Cdh1Δ mice does not affect BAL cytokine levels and its cellular composition (Fig.  4). Based on the 
fact that E-cadherin is a cell adhesion molecule, one could hypothesize that E-cadherin+ alveolar mac-
rophages could interact with E-cadherin+ epithelial cells in the lung, enabling their trapping and reten-
tion. However, since BAL macrophage counts were similar in Cdh1Δ and Cdh1F/F asthmatic mice, we 
have no evidence to support this hypothesis. Remarkably, B cell numbers were always lower in the BAL 
of ovalbumine-challenged Cdh1Δ mice. While some B cell subsets are reported to express a nonclassical 
cadherin during B cell development41, we did not detect any E-cadherin-expressing CD11b-negative 
cells (including B cells) in the BAL of asthmatic mice (Fig. 2A). In addition, these B cells did not express 
the other E-cadherin ligands CD103 and KLRG1 (data not shown) and therefore it seems unlikely that 
the reduced B cell counts in the BAL of allergic Cdh1Δ mice can be explained by a reduced trapping of 
those cells by E-cadherin-deficient alveolar macrophages. Hence, why B cell numbers are reduced during 
ovalbumin-induced allergic asthma in macrophage-specific E-cadherin-deficient mice remains unknown. 
Of note, while LysM-Cre x Cdh1F/F mice are considered to be macrophage -specific E-cadherin-deficient 
mice, the DCs in the BAL of ovalbumine-challenged mice also displayed abrogated E-cadherin expres-
sion (Fig. 4A). Hence, alveolar DCs during allergic asthma display active lysozyme M promoters, which 
is in agreement with previous publications reporting lysozyme expression by some DC subsets42,43. 
In any case, deletion of E-cadherin in alveolar macrophages and DCs does not affect the degree of 
ovalbumin-induced experimental airway inflammation. Thus, while E-cadherin supresses inflammatory 
signaling in macrophages in vitro, these effects are clearly not strong enough to alter the overall mac-
rophage activation status during polarized Th2 responses in vivo.
Overall, employing macrophage-specific E-cadherin-deficient mice, we demonstrate that E-cadherin 
in macrophages is largely unnecessary for in vivo granuloma formation, and for the regulation of Th2 
responses. Irrespective of its in vivo redundancy, the E-cadherin/catenin complex offers a valuable tool 
to detect M(IL-4/IL-13) macrophages in vivo.
Methods
Ethics Statement. The study was carried out in strict accordance with the recommendations in 
‘Guidelines for the Use of Laboratory Animals in Research, Teaching and Testing’ of the International 
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Council for Laboratory Animal Science. The permission of the local authorities has been given (accredi-
tation N° LA1210220) and all animal work was approved by the appropriate committee (‘Ethische com-
misie voor dierproeven’) at the Vrije Universiteit Brussel (ethics committee protocol number 07-220-03).
E-cadherin-overexpressing Raw264.7 cell lines. The generation of Raw264.7-E-cadherin trans-
fectants were described previously6.
Mice. To generate mice in which the E-cadherin gene was disrupted in macrophages, floxed 
Cdh1F/F C57BL/6 mice (kind gift of Dr. J Jonkers, The Netherlands Cancer Institute, Amsterdam, The 
Netherlands44) were crossed with LysM-Cre C57BL/6 mice (Jackson Laboratory, Bar Harbour, Maine, 
USA45). Homozygous LysM-Cre+/+-Cdh1F/F conditional KO (hereafter referred to as Cdh1Δ) mice were 
compared to LysM-Cre−/−-Cdh1F/F littermate controls (hereafter referred to as Cdh1F/F). In Cdh1Δ mice 
the IL-4-induced E-cadherin expression, either upon in vitro stimulation or during in vivo pathologies is 
ablated in > 90% of the macrophages6.
Disease models. To study cysticercosis, mice were inoculated intraperitoneally (ip) with 10 Taenia 
crassiceps cestodes, and peritoneal cells and helminths were collected at different time intervals post 
infection for further analysis35. To study the involvement of macrophage E-cadherin expression during 
granuloma formation in the lung, mice were injected intravenously (iv) with 5000 Schistosoma mansoni 
ova, were sacrificed 7 or 14 days later and the lungs were fixed and removed for further analysis (adapted 
from24).
To sensitize mice for allergic asthma, animals were injected ip at day 0 and 7 with 10 μ g grade V 
chicken egg ovalbumin (OVA; Sigma) adsorbed on 1 mg Alum (Pierce, Rockford, IL) in PBS. Next, mice 
were challenged at day 14 and 15 (2× OVA, short term protocol) or at day 14, 15, 21 and 22 (4× OVA, 
long term protocol) for 30 min with aerosols, consisting of 1% grade III OVA in PBS46. 20 h after the 
last challenge, mice were sacrificed and broncho-alveolar lavage (BAL) was performed by PBS rinsing 
of the lungs. The BAL fluid (BALF) was centrifuged and supernatant and cell pellets were collected for 
further analysis.
In vitro stimulation of macrophages. Bone marrow-derived macrophages (BMDM) were generated 
from naïve mice as detailed earlier6. Peritoneal macrophages from Taenia crassiceps infected mice were 
obtained by rinsing the peritoneum with PBS/10% sucrose. After 3 h culture, non-adherent cells were 
washed away and plastic-adherent macrophages were used for analysis. Macrophages were cultured for 
24 h in RPMI1640 medium supplemented with 10% heat-inactivated FCS, 0.03% L-glutamine, 100 mg/
mL streptomycin and 100 mg/mL penicillin, 1 mM nonessential amino acids, 1 mM sodium pyruvate (all 
from Invitrogen, Carlsbad, CA) and 0.02 mM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO) in the 
presence of 0.1, 1 or 10 ng/ml E. coli LPS with or without 10 U/ml recombinant mouse IFN-γ or in the 
presence of 20 ng/ml recombinant mouse IL-4 (BD Bioscience).
Cytokine, NO and arginase measurement. Cytokines in the macrophage culture supernatants 
were quantified with sandwich ELISAs for TNF (R&D Systems, Minneapolis, MN), IL-6, IL-12 and IL-10 
(BD Pharmingen), in accordance to the suppliers’ protocols. Cytokine levels in BALF were measured by 
Bio-Plex (Bio-Rad, Hercules, CA). NO2− in culture supernatants was quantified by a standard Griess 
reaction47. Arginase activity was measured as described earlier48.
Flow cytometry and analysis of E-cadherin expression. Quantitative real-time PCR, Western 
blot and flow cytometry for E-cadherin mRNA and protein expression was performed as described 
earlier6. Gating on distinct immune cell types during the different disease models is shown in Figures S2 
and S3. All antibodies are listed in Table  1. Data were acquired with a FACSCantoII (BD Biosciences) 
and analyzed using FlowJo (TreeStar, Ashland, OR).
Schistosoma mansoni granuloma histopathology. For measurement of Schistosoma mansoni 
granulomas, lungs (5 mice per group) were inflated with a 1:1 PBS/Tissue-Tek OCT compound (Gentaur, 
Kampenhout, Belgium) mixture and stored at − 20 °C. Next, 7 μ m sections were prepared with a Leica 
CM1950 cryostat, stained with Hematoxilin-Eosin (HE) and acquired on Nikon Elipse 600 microscope 
using a Digital Sight DS-U2 and a 10× /0.25 (Ph1 DL WD 10.5), 20× /0.4 (Ph1 DL WD1.3) or a 40× /0.65 
(Ph2 DL WD 0.57) objective lense (all from Nikon Instruments Inc., Lewisville, TX). At least 20 granu-
lomas per mouse were analysed using ImageJ (National Institutes of Health). The volume of each granu-
loma was calculated as 4/3*Π *r3, the cross-sectional area was determined by ImageJ, the cell density was 
counted as the amount of cells per area of 10 μ m2 and the percentage eosinophils in each cross-sectional 
area was evaluated manually.
Statistics. Statistical significance was tested via the unpaired t test using GraphPad Prism 4 (GraphPad 
Software, San Diego, CA).
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